Terumo (OTCMKTS:TRUMY) Issues Quarterly Earnings Results

Terumo (OTCMKTS:TRUMY) issued its earnings results on Wednesday. The company reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16, Zacks reports. The business had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.75 billion. Terumo had a return on equity of 9.19% and a net margin of 12.09%.

Terumo Trading Up 0.6%

OTCMKTS:TRUMY traded up $0.09 during mid-day trading on Friday, reaching $15.28. 63,577 shares of the company’s stock traded hands, compared to its average volume of 157,998. The company has a 50 day moving average price of $16.63 and a 200-day moving average price of $17.57. The firm has a market capitalization of $22.63 billion, a price-to-earnings ratio of 26.81 and a beta of 0.77. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.64 and a quick ratio of 1.53. Terumo has a 12-month low of $14.74 and a 12-month high of $21.22.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.